1. Home
  2. EE vs INBX Comparison

EE vs INBX Comparison

Compare EE & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Excelerate Energy Inc.

EE

Excelerate Energy Inc.

HOLD

Current Price

$35.79

Market Cap

1.2B

Sector

Utilities

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$109.32

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EE
INBX
Founded
2003
2010
Country
United States
United States
Employees
1046
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
999.7M
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
EE
INBX
Price
$35.79
$109.32
Analyst Decision
Buy
Buy
Analyst Count
5
3
Target Price
$39.20
$150.00
AVG Volume (30 Days)
362.3K
586.3K
Earning Date
05-06-2026
05-15-2026
Dividend Yield
0.96%
N/A
EPS Growth
0.79
N/A
EPS
0.37
N/A
Revenue
$1,228,263,000.00
$1,300,000.00
Revenue This Year
$23.59
N/A
Revenue Next Year
$24.37
N/A
P/E Ratio
$97.89
N/A
Revenue Growth
44.26
550.00
52 Week Low
$21.29
$12.80
52 Week High
$43.18
$155.29

Technical Indicators

Market Signals
Indicator
EE
INBX
Relative Strength Index (RSI) 55.89 50.41
Support Level $35.10 $69.30
Resistance Level $43.18 $155.29
Average True Range (ATR) 1.44 13.20
MACD 0.26 -3.55
Stochastic Oscillator 80.54 23.22

Price Performance

Historical Comparison
EE
INBX

About EE Excelerate Energy Inc.

Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: